Records containing: Pain, Intractable
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-05-06The Role of Radiocontrast Media in Pulsed Radiofrequency Treatment of Lumbar Dorsal Root Ganglion
-
CLINICAL_TRIALS study record update · 2020-04-08Cerebral PET Patterns, Inflammatory Biomarkers and Outcome in Patients Treated With Burst Spinal Cord Stimulation for Chronic Low Back and Leg Pain: A Randomized Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-03-19BurstDR™ micrOdosing stimuLation in De-novo Patients
-
CLINICAL_TRIALS study record update · 2019-09-11Comparison Between Ropivacaine/Dexamethasone and 10% Lignocaine Injection in Distal Glossopharyngeal Nerve Block for Intractable Cancer Pain- A Randomized Trial
-
CLINICAL_TRIALS study record update · 2019-09-10Prospective Multi-center Study of Impact of Femoral "Y-strut" Implant on Pain and Quality of Life in Patients With Lytic Bone Metastases of the Femoral Neck
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-05-15A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain
-
CLINICAL_TRIALS study record update · 2018-02-23A Prospective, Randomized, Double Blind, Crossover, Multi-center Study to Evaluate the Safety and the Efficacy of Motor Cortex Stimulation With the Cortical Stimulation Lead Model 2976 in Patients With Neuropathic Pain
-
CLINICAL_TRIALS study record update · 2017-09-19A Prospective, Multi-center, Open-label Study of Programming Options in Spinal Cord Stimulation.
-
CLINICAL_TRIALS study record update · 2017-07-11Low-dose Ketamine as Adjuvant Treatment to Morphine in Neuropathic Cancer Pain
-
CLINICAL_TRIALS study record update · 2017-06-16Long-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain
-
CLINICAL_TRIALS study record update · 2017-06-01A Multicenter Longitudinal Observational Study Evaluating Genotypic Association wIth Clinical Outcomes in Interventional Pain Management Modalities
-
CLINICAL_TRIALS study record update · 2016-11-03Efficacy and Safety of Wound Dressing Containing Silk Fibroin With Bioactive Coating Layer Versus Medicated Paraffin Gauze Dressing in the Treatment of Split-thickness Skin Graft Donor Sites
-
CLINICAL_TRIALS study record update · 2016-09-20A Double Blind Randomized Clinical Trial to Investigate the Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic Therapy in Cancer Patients With Pain
-
CLINICAL_TRIALS study record update · 2015-04-02Clinical Efficacy of Wound Dressing Containing Silk Sericin for Split-thickness Skin Graft Donor Site Treatment
-
CLINICAL_TRIALS study record update · 2014-05-26Evaluation of Stepped Care for Chronic Pain in Iraqi/Afghanistan Veterans
-
CLINICAL_TRIALS study record update · 2012-10-26Stimulus Confirmatory Study - An Implantable Spinal Cord Stimulation Pain Management System
-
CLINICAL_TRIALS study record update · 2011-09-27A Randomized Placebo-Controlled Trial Of The Efficacy And Tolerability Of Flexibly Dosed Pregabalin In The Treatment Of Cancer-Induced Bone Pain
-
CLINICAL_TRIALS study record update · 2011-02-01An Open Label Study to Confirm the Effectiveness, and Safety of Fentanyl Transdermal Matrix Patch in Japanese Patients With Chronic Intractable Pain Who Has Prior Therapy of Codeine, Morphine Hydrochloride, or Fentanyl Injectable Preparations.
-
CLINICAL_TRIALS study record update · 2011-01-24Open Label Study to Confirm Effectiveness, Safety and Pharmacokinetics of Fentanyl Transdermal Matrix Patch, in Japanese Patients With Cancer Pain Who Have Had a Minimum Amount of Morphine Therapy, Such as Equal to Less Than 45 mg/Day of Oral Morphine or Oxycodone Equal to Less Than 30 mg/Day.